Clinical Trial Update: Study of the Safety of Intravenous Artesunate [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety of intravenous artesunate in malaria-related conditions, with completed status and results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Malaria
• Malaria

Drugs mentioned

• Artesunate (artesunate)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria, Malaria, Cerebral | Phase 1 | Status: COMPLETED | Results posted: 2018-10-25